Source: PRWeb

Press Release: Precision Health AI : Predicting Response to Treatment to Prevent Breast Cancer Patients From Dying of Side Effects: Precision Health AI Publishes Ground Breaking Predictive Results

Predicting Response to Treatment to Prevent Breast Cancer Patients From Dying of Side Effects: Precision Health AI Publishes Ground Breaking Predictive Results for Treatment Outcomes and Real World Data Driven Analysis of Care Variation in Targeted and IO Treatment at ASCO AI Model Results for Prediction of the Occurrence of Chemotherapeutic Induced Neutropenia Exceed Current Prediction Accuracy Standards by >50%. Precision Health AI, a SymphonyAI company, to present findings and other accepted publications at ASCO Meeting.(PRWeb May 17, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15499156.htm

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Brigham Hyde's photo - Founder & CEO of Precision Health AI

Founder & CEO

Brigham Hyde

CEO Approval Rating

74/100

Read more